Sanofi leans on COPD as 'next major growth pillar' for its immunology star Dupixent: CEO
25th April 2024 Uncategorised 0 Sanofi leans on COPD as ‘next major growth pillar’ for its immunology star Dupixent: CEO
fkansteiner
Thu, 04/25/2024 – 11:32
More: Sanofi leans on COPD as 'next major growth pillar' for its immunology star Dupixent: CEO
Source: fierce
